http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012087115-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ee00e8be0567847aeb64787e9af4f02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_117a066dacb4cf6922070021a883a821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7536304cb278cdeed0a305226ddfaced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da36e254ce2f9e2d38814fd3f6a2d9c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-88
filingDate 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_196b8be009e10f051cbe314dbae0416a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2f50fef0712d88c0bb89c16905e7608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf71fc5cdff02fcf0571e93d5cc23c08
publicationDate 2013-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012087115-A8
titleOfInvention Cancer targeting using carbonic anhydrase isoform ix inhibitors
abstract The present invention concerns novel carbonic anhydrase IX inhibitors comprising a nitroimidazole moiety and their use in therapy of hypoxic conditions, in particular cancer treatment, especially chemotherapy and radiotherapy. The compounds of the invention have an increased specificity for the carbonic anhydrase IX enzyme compared to the art. The present invention relates to novel nitroimidazole derivates represented by formula (1).
priorityDate 2010-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8VHB5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10701
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543317
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ16790
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43264
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID566612
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID230099

Total number of triples: 32.